Block on Trump's Asylum Ban Upheld by Supreme Court
The innovative, too good to be true, movie ticket service, MoviePass has filed a patent infringement action against its new competitor Sinemia. And while MoviePass may not be able to prevent competitors from entering into the newly created space, it can certainly try to stamp out those competitors that steal their tech.
If you like going to the movies (but hate the rising price of movie tickets), and haven't heard of MoviePass, you'll want to read on to learn how this innovative service works.
Basically, for $10 per month, the MoviePass service will let you go see one movie per day for free. The big, but not really huge, caveats: No 3D or IMAX, it has to be you, and no more than one movie per day (using MoviePass). After a person signs up, they receive a MoviePass debit card and have to download a MoviePass app to their smartphone. Then when they arrive at the theater to see the movie of their choosing (at a theater that accepts MoviePass -- of which, there are plenty), the MoviePass movie goer checks in on their phone, which then automatically loads their debit card with the value of the ticket, which they can then use to buy their movie ticket.
The service started in 2011, but did not actually take off until it dropped the monthly subscription fee from $50 to $10.
What's the Case About?
In short, the case involves MoviePass's claim that Sinemia copied their app and pretty much their entire set up, including the use of an app coupled with a branded debit card to verify a movie goers location and identity. And while Sinemia offers differing price points and subscription levels, MoviePass's lawsuit is about the seemingly flagrant copying of the technology used to implement the innovative service.